Bio-Rad Laboratories, Inc.Class A vs. EyePoint, Inc. Common Stock
BIO
Bio-Rad Laboratories, Inc.Class A
$356.32 +0.02%
VS EYPTEyePoint, Inc. Common Stock
$4.87 -66.98%
Bio-Rad Laboratories, Inc.Class A (BIO) comes out ahead, leading on 7 of 8 compared factors.
Size & Scale
| BIO | EYPT | |
|---|---|---|
| Market Cap | $9.53 billion | $1.27 billion |
| Revenue (TTM) | $2.59 billion | $2.79 million |
| Net Income (TTM) | $222.40 million | $-306,643,000 |
BIO leads on 3 of 3 size & scale factors.
Valuation
| BIO | EYPT | |
|---|---|---|
| P/E Ratio | 43.40 | — |
| Price / Book | 1.33 | 7.64 |
| Price / Sales | 3.68 | 455.94 |
BIO leads on 2 of 2 valuation factors.
Profitability
| BIO | EYPT | |
|---|---|---|
| Net Margin | 8.59% | -10994.73% |
| Return on Equity | 3.10% | -184.27% |
BIO leads on 2 of 2 profitability factors.
Risk & Sentiment
| BIO | EYPT | |
|---|---|---|
| Short Interest | 2.44% | 1.22% |
EYPT leads on 1 of 1 risk & sentiment factors.
Dig deeper: BIO overview, BIO financials, EYPT overview, EYPT financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.